US3896817A - Implantable nerve stimulator - Google Patents

Implantable nerve stimulator Download PDF

Info

Publication number
US3896817A
US3896817A US277963A US27796372A US3896817A US 3896817 A US3896817 A US 3896817A US 277963 A US277963 A US 277963A US 27796372 A US27796372 A US 27796372A US 3896817 A US3896817 A US 3896817A
Authority
US
United States
Prior art keywords
signal
amperage
nerve
pacer
battery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US277963A
Inventor
Thomas F Hursen
Steve Andrew Kolenik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermedics Inc
Original Assignee
Arco Nuclear Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arco Nuclear Co filed Critical Arco Nuclear Co
Priority to JP8644973A priority Critical patent/JPS4992885A/ja
Priority to FR7328542A priority patent/FR2194456B1/fr
Priority to BE1005277A priority patent/BE803162A/en
Application granted granted Critical
Publication of US3896817A publication Critical patent/US3896817A/en
Assigned to INTERMEDICS, INC. reassignment INTERMEDICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: ARCO MEDICAL PRODUCTS COMPANY
Assigned to TRUST COMPANY BANK, CITIBANK, N.A., AS AGENT, BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION,, BRAZOSPORT BANK OF TEXAS, CHASE MANHATTAN BANK, N.A., THE, FIRST FREEPORT NATIONAL BANK, FIRST NATIONAL BANK OF CHICAGO, THE reassignment TRUST COMPANY BANK SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). SUBECT TO CONDITIONS INVOLVING SAID PATENTS IN SCHEDULE II (SEE DOCUMENT FOR DETAILS) Assignors: AMERICAN PACEMAKER CORPORATION, CALCITEK, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., INTERMEDICS, INC., INTERVASCULAR, INC., MASTER IMAGES, INC., NEUROMEDICS, INC., SURGITRONICS CORPORATION
Assigned to CHASE COMMERCIAL CORPORATION reassignment CHASE COMMERCIAL CORPORATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION, A CORP. OF MA., CALCITEK, INC., A CORP. OF TEXAS, CARBOMEDICS, INC., INTERMEDICS CARDIASSIST, INC., A CORP OF TX., INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS, INTERMEDICS, INC., A CORP. OF TEXAS, NEUROMEDICS INC., A CORP. OF TEXAS, SURGITRONICS CORPORATION, A CORP. OF TEXAS
Assigned to B.A. LEASING CORPORATION reassignment B.A. LEASING CORPORATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION, A CORP. OF MA., CALCITEK, INC., CARBOMEDICS, INC.,, INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS, INTERMEDICS, INC., A CORP. OF TEXAS, NEUROMEDICS, INC., A CORP. OF TEXAS, SURGITRONICS CORPORATION, A CORP. OF TEXAS
Assigned to CITICORP MILTILEASE (SEF), INC. reassignment CITICORP MILTILEASE (SEF), INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATON, A CORP. OF MA., CALCITEK, INC., A CORP. OF TEXAS, CARBOMEDICS, INC., A CORP. OF TEXAS, INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS, INTERMEDICS, INC., NEUROMEDICS, INC., SURGITRONICS CORPORATION, A CORP. OF TEXAS
Assigned to CITIBANK, N.A. reassignment CITIBANK, N.A. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION A MA CORP., CALCITEK, INC., A TX CORP., CARBOMEDICS, INC., A TX CORP., INTERMEDICS CARDIASSIST, INC., A TX CORP., INTERMEDICS INTRAOCULAR, INC., A TX CORP., INTERMEDICS, INC., A TX CORP, NEUROMEDICS, INC., A TX CORP, SURGITRONICS CORPORATION A TX CORP.
Assigned to INTERMEDICS, INC. reassignment INTERMEDICS, INC. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITICORP MULTILEASE (SEF), INC.
Assigned to INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., TEXAS CORPORATION AND AMERICAN PACEMAKER CORPORATION, A CORP OF MASS. reassignment INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., TEXAS CORPORATION AND AMERICAN PACEMAKER CORPORATION, A CORP OF MASS. SECURED PARTY HEREBY RELEASE THE SECURITY INTEREST IN AGREEMENT RECORDED AUGUST 5, 1985. REEL 4434 FRAMES 728-782 Assignors: CITIBANK, N.A.
Assigned to INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., INTERVASCULAR, INC., AND MASTER IMAGES, INC., TEXAS CORPORATIONS, AND AMERICANPACEMAKER CORPORATION, A CORP. OF MA. reassignment INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., INTERVASCULAR, INC., AND MASTER IMAGES, INC., TEXAS CORPORATIONS, AND AMERICANPACEMAKER CORPORATION, A CORP. OF MA. SAID PARTIES RECITES OBLIGATIONS RECITED IN SECURITY AGREEMENT RECORDED SEPTEMBER 17, 1984 REEL 4303 FRAMES 077-127 HAVE BEEN PAID IN FULL ALL SEE RECORD FOR DETIALS Assignors: CITIBANK, N.A., INDIVIDUALLY AND AS AGENT FOR BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION, THE CHASE MANHATTAN BANK, N.A., THE FIRST NATIONAL BANK OF CHICAGO, TRUST COMPANY BANK, FIRST FREEPORT NATIONAL BANK OF BRAZOSPORT BANK OF TEXAS
Assigned to MAY PARTNERSHIP, THE reassignment MAY PARTNERSHIP, THE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION A MA CORP., CALCITEK, INC., CARBOMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INFUSAID, INC. TX CORPS., INTERMEDICS, INC.,, SURGITRONICS CORPORATION
Assigned to CARBOMEDICS, INC., A TEXAS CORP., AMERICAN PACEMAKER CORPORATION, A MASSACHUSETTS CORP., CALCITEK, INC., A TEXAS CORP., INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP., INTERMEDICS, INC., A TEXAS CORP., INTERMEDICS CARDIASSIST, INC., A TEXAS CORP., NEUROMEDICS, INC., A TEXAS CORP., SURGITRONICS CORPORATION, A TEXAS CORP. reassignment CARBOMEDICS, INC., A TEXAS CORP. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: B. A. LEASING CORPORATION
Assigned to INTERMEDICS INTRAOCULAR, INC., INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., CARBO-MEDICS, INC., SURGITRONICS CORPORATION reassignment INTERMEDICS INTRAOCULAR, INC. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CHASE COMMERCIAL CORPORATION
Assigned to INTERMEDICS, INC. reassignment INTERMEDICS, INC. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). RECORDED AT REEL 4581, FRAMES 501-531 (SEE RECORD FOR DETAILS) Assignors: MAY PARTNERSHIP, THE, BY: ROLLINS HOLDING COMPANY, INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/378—Electrical supply

Definitions

  • An implantable stimulator for a nerve includes 3 voltage amplifier, a voltage regulator, a pulse generator, a pulse train generator, a pulse amplitude modulator, and at least one flexible conduit to a nerve, such stimulator being powered by the combination of a nucleonic heat generator, and a thermopile for converting thermal energy to electric energy.
  • Each train of pulses is regulated so that the gradual variation in the amperage is from 25 per cent to 95 per cent more than the minimum amperage.
  • a saw tooth pulse signal more closely simulates the biological stimulation of a nerve.
  • the nerve stimulator is particularly effective as a nuclear-powered respiratory pacer for energizing a phrenic nerve for controlled breathing of a mammal.
  • This invention relates to prosthetic electrical devices which can be placed within the body to provide electrical signals effectively stimulating a nerve.
  • a nerve pacer comprises the combination of a nuclear battery, an electrical pulse train generator, and a modulator adapted to provide a signal having a maximum amperage at least 25 per cent greater but not more than 95 per cent greater than the minimum amperage of such signal, whereby the nerve is stimulated by a signal which varies in a manner achieving a desired biological effect.
  • An implantable nerve stimulator features the combination of a nuclear battery and electronic circuitry providing signals consisting of a train of a controlled number of pulses of direct current.
  • An implantable respiratory pacer having an output of a range of from about 1 to 5 milliwatts and powered by a nuclear battery stimulates one or more phrenic nerve to provide a controlled rate of breathing for the mammal.
  • a respiratory pacer 10 features a nuclear battery 11.
  • a radioisotope heat source 12 energizes a thermopile 13 to generate a voltage energizing the respiratory pacer.
  • the battery voltage is modified by a voltage amplifier l4 and a constant voltage regulator 15.
  • Electrical circuit means energized by the voltage from said regulator 15 energizes a pulse generator, the electrical circuitry for such pulse generator comprising an oscillator.
  • a pulse train generator 17 assures the absence of current flow during significant intervals, with a train of pulses between intervals, for example, 18 intervals per minute, corresponding to a relaxed breathing rate.
  • a signal amperage modulator 18 transforms each train of pulses into a saw tooth signal having an end peak from per cent to per cent to the initial portion of such signal, thus more nearly simulating the natural signal to a phrenic nerve.
  • Conductors l9 and 20 transmit such saw tooth signal to left and/or right phrenic nerves.
  • the electrical circuit means and nuclear battery are hermetically sealed in a casing 21.
  • a pulse train generator to provide a signal consisting of a controlled series of direct current pulses is a novel feature of the present nerve stimulator.
  • the step of modulating the amperage to provide a saw tooth signal having an end peak from 125 per cent to 195 per centof the initial portion of a signal is a novel and significant forward step of the present invention.
  • Previous nervestimulators have generally lacked the novel adjustable 'means for allocating electrical energy amongst a plurality of conductors, so that the provision of the load isolation and distribution regulator should be given special consideration.
  • This invention represents a medical break-through as the first device adapted for placement or implantation within the body and featuring the combination of nucleonic battery and a conduit stimulating the phrenic nerve.
  • the unique'nuclear battery makes feasible the first respiratory pacer sufficiently durable and compact to be carried within the body after surgical implantation.
  • the nerve stimulator serves to actuate the phrenic nerve to provide a respiratory pacer.
  • a radioisotope provides a continuing radioactivity which is transformed into heat and the heat is transformed into a low voltage electric current.
  • a voltage amplifier converts the DC voltage to a more useful direct current voltage which is maintained constant by a constant voltage regulator.
  • a self-starting oscillator regulates the conversion of the constant direct current to a square wave series of direct current pulses having a frequency of about 90 pulses per second, each pulse having a duration of about 132 microseconds.
  • a significant difference from a conventional cardiac pacer concerns a pulse train generator adapted to provide a train of pulses followed by an interval each signal being a train of pulses.
  • a respiratory pacer about 18 signals per minute are appropriate, the interval between the signals being about 24 per cent greater than the signal duration.
  • Each signal can be about 1.49 seconds and the interval between signals about 1.85 seconds.
  • An important feature of the present invention is the provision of a modulator adapted to alter the train of pulses in a signal so that the peak amperage during a particular signal is at least 25 per cent greater than the minimum amperage during such signal.
  • Various patterns of modulation of the signal are appropirate but particular advantages arise from the control of a saw tooth train having a relatively lower amperage at the beginning of the signal than at the end of the signal, with the amperage increasing during the continuation of the signal. It is sometimes desirable for a signal remote from this invention to have a saw tooth pattern involving an increase which is several hundred per cent over the minimum amperage but such a steep increase in amperage during the signal does not appear to closely simulate a neurological signal.
  • the saw tooth increase modulates the signal so that the amperage of the terminal portion of the signal of the present invention is from about 125 per cent to about 195 per cent of the amperage of the initial signal, whereby the simulation of the natural neurological signal is more accurately achieved.
  • a load isolation regulator is advantageously included in the respiratory pacer to permit adjustment of the intensity of the phrenic nerve signal for each of the two nerves; that is, the left phrenic nerve and the right phrenic nerve.
  • a manually adjustable potentiometer can split the power between the two phrenic nerves.
  • a conductor extends from the respiratory pacer to the phrenic nerve. Such conductor is advantageously detachably connected to the respiratory pacer.
  • a preferred embodiment of the invention can be further clarified by description of a respiratory pacer.
  • Nuclear Battery Plutonium 238 has a half life of 86.4 years, and has numerous advantages for a nuclear battery. About 2 watts of power are generated, theoretically, by the amount of plutonium employed in the battery, but much of the energy is dissipated.
  • the electrical output of the battery is of the general magnitude of the range of 0.001 to 0.005 watt, or about I to milliwatts.
  • the energy utilization efficiency of the battery and/or nerve stimulator is in the range from about 0.1 per cent to l per cent.
  • a plutonium-type battery having a size of about 1 /2 inches diameter and l l/16 inch thick weighs about 92 grams.
  • thermocouple The voltage resulting from a thermocouple is amplified by a DC voltage amplifier to provide the electric current suitable for the electronic circuitry.
  • the oscillator modifies the current by a square wave series of pulses of direct current having a frequency of about 89 pulses per second. Each pulse has a width or duration of about 132 microseconds or 0.132 milliseconds.
  • a pulse train generator transforms the pulses into signals at a range of about 18 signals per minute, the intervals between signals being about 24 per cent greater than the duration of the signals.
  • the signal is about l.49 seconds and the interval between signals about 1.85 seconds.
  • the maximum pulse amplitude is about 9.6 milliamps.
  • the pulse amplitude modulation is about 54 per cent.
  • the maximum amperage is within the range from per cent to per cent of the minimum amperage by reason of the control of the modulation of the signal.
  • the respiratory pacer is hermetically sealed in a flat cylindrically shaped titanium can having a diameter of about 2% inches and about 1% inches thick. Such hermetic sealing protects the contents from adverse effects of liquids between organs within the body, whereby it may be implanted within a living body.
  • the respiratory pacer weighs about 198 grams, thus being similar in weight and dimensions to a battery powered cardiac pacer having an output of about one-twentieth of the power of a phrenic nerve stimulator.
  • a signal having a saw tooth shape can have a substantially uniform increase of amperage during the 1.49 seconds of the signal.
  • the modulation circuitry is adapted to provide up to about 54 per cent modulation of the maximum signal and to achieve saw tooth wave signal.
  • the maximum amperage of the signal should be at least 25 per cent greater than the minimum amperage of the signal, and should be less than 95 per cent of such minimum.
  • electrical means converting electrical power from said battery to a series of signals having a frequency per minute corresponding approximately to the desired breathing rate, each signal comprising a plurality of direct current pulses, one output terminal being a connector and the other output terminal for said electrical means being the hereinafter recited casing adapted to contact liquids between organs within the body, some such liquids being where the pacer is implanted, said electrical means including means for modulating the amperage of a signal so that its maximum amperage is within the range from about 125 per cent to about 195 per cent of the minimum amperage of such signal;
  • a casing containing said battery, electrical means, and said connector for said conductor, said casing hermetically sealing its contents from adverse effects attributable to said liquids, whereby the respiratory pacer may be implanted within a living body.
  • an implantable nerve stimulator comprising at least one conductor transmitting signals toward a nerve, the improvement which includes:
  • hermetic sealing means for said casing adapted to protect the contents of the casing from adverse effects attributable to liquids between organs;
  • electrical circuit means converting electrical power from said battery to signals consisting of a controlled train of direct current pulses transmitted by said conductor, said circuit means including means for modulating the amperage of a signal so that its maximum amperage is within the range from about per cent to about per cent of the minimum amperage of such signal.
  • the nerve stimulator of claim 2 in which the train of pulses constituting said signal has'a sawtooth pattern with maximum amperage at about the terminal portion of the signal and a minimum amperage at about the initial portion of the signal.
  • the nerve stimulator of claim 2 in which there are a plurality of conductors and manually adjustable distribution means allocating the signal energy flowing respectively toward the right phrenic nerve and the left phrenic nerve.
  • a nuclear powered respiratory pacer in accordance with claim 2 in which the output flowing toward at least one phrenic nerve is within the range from about 1 to about 5 milliwatts.
  • a nuclear powered respiratory pacer in accordance with claim 5 in which the nuclear battery weighs about 92 grams and contains plutonium 23 8 as the radioisotope heat source.

Abstract

An implantable stimulator for a nerve includes a voltage amplifier, a voltage regulator, a pulse generator, a pulse train generator, a pulse amplitude modulator, and at least one flexible conduit to a nerve, such stimulator being powered by the combination of a nucleonic heat generator, and a thermopile for converting thermal energy to electric energy. Each train of pulses is regulated so that the gradual variation in the amperage is from 25 per cent to 95 per cent more than the minimum amperage. A saw tooth pulse signal more closely simulates the biological stimulation of a nerve. The nerve stimulator is particularly effective as a nuclear-powered respiratory pacer for energizing a phrenic nerve for controlled breathing of a mammal.

Description

United States Patent Hursen et al.
[451 July 29, 1975 IMPLANTABLE NERVE STIMULATOR [75] Inventors: Thomas F. l-lursen, Monroeville;
Steve Andrew Kolenik, Leechburg, both of Pa.
[73] Assignee: Arco Nuclear Company, Leechburg,
[22] Filed: Aug. 4, 1972 [21] Appl. No.: 277,963
[30] Foreign Application Priority Data Aug. 6, 1971 United Kingdom 37l5l/7l [52] US. Cl... 128/419 R [51] Int. Cl A6ln H36 [58] Field of Search 128/419 P,4l9 R, 421, 128/422, 423,28
[56] References Cited UNITED STATES PATENTS 2,711,729 6/1955 Hofmann 128/421 3,077,884 2/1963 Batrow et a1. 128/423 3.486.506 12/1969 Auphan 128/419 P 3,600,586 8/1971 Barthelemy et al. 128/419 P Eli/5267265 PEGUL A 70? 3,649,367 3/1972 lurdy 128/419 P FOREIGN PATENTS OR APPLICATIONS 152,266 11/1955 Sweden 128/419 R Primary ExaminerWilliam E. Kamm Attorney, Agent, or FirmJohn R. Ewbank [57] ABSTRACT An implantable stimulator for a nerve includes 3 voltage amplifier, a voltage regulator, a pulse generator, a pulse train generator, a pulse amplitude modulator, and at least one flexible conduit to a nerve, such stimulator being powered by the combination of a nucleonic heat generator, and a thermopile for converting thermal energy to electric energy. Each train of pulses is regulated so that the gradual variation in the amperage is from 25 per cent to 95 per cent more than the minimum amperage. A saw tooth pulse signal more closely simulates the biological stimulation of a nerve. The nerve stimulator is particularly effective as a nuclear-powered respiratory pacer for energizing a phrenic nerve for controlled breathing of a mammal.
6 Claims, 1 Drawing Figure PULSE GQVQPATOP yam/0) TPA/N 17 IMPLANTABLE NERVE STIMULATOR CROSS NOTATION TO CONVENTION APPLICATION Reference is made to British Provisional application 37,151 of 1971 filed Aug. 6, 1971 on License No. 351,021 issued July 6, 1971, applicant claiming convention priority. All the disclosure of said 37,151 is deemed here reiterated. Reference is made to US. Pat. No. 3,818,304, derived from Ser. No. 171,383 and parent Ser. No. 827,187, filed May 23, 1969, assigned to common assignee, Atlantic Richfield Company, of which this is a continuation-in-part, disclosing some embodiments of nuclear batteries of sufficient power for a respiratory pacer.
FIELD OF THE INVENTION This invention relates to prosthetic electrical devices which can be placed within the body to provide electrical signals effectively stimulating a nerve.
PRIOR ART Some disfunction in mammals are attributable to the reliability of a controlled frequency of nerve stimulations for actuating appropriate muscles. Cardiac pacers have been helpful in dealing with certain disfunctions of the heart attributable to neurological problems. The breathing disfunction of a neurological nature are similarly dealt with by respiratory pacers stimulating one or more of the phrenic nerves at appropriate intervals. Significant greater wattage is required in a respiratory pacer than in a cardiac pacer.
An implantable cardiac pacer featuring a nuclear battery has heretofore been proposed in the commonly assigned patent application U.S. Ser. No. 109,857, (now abandoned and replaced by Ser. No. 325,473) all the disclosure of which is deemed here reiterated. A lecture providing background information concerning respiratory pacers was presented at the American Association for Thoracic Surgery by Seymour Furman et a1, entitled Transvenous Stimulation of the Phrenic Nerves about Apr. 27, 1971, all the disclosure of which is deemed here reiterated. Although there has been a recognition that the phrenic nerve sometimes benefited from stimulation by a pacer, there had not been any answer to the problem of an implantable phrenic nerve stimulator prior to the development of the present invention.
SUMMARY OF THE INVENTION In accordance with the present invention, a nerve pacer comprises the combination of a nuclear battery, an electrical pulse train generator, and a modulator adapted to provide a signal having a maximum amperage at least 25 per cent greater but not more than 95 per cent greater than the minimum amperage of such signal, whereby the nerve is stimulated by a signal which varies in a manner achieving a desired biological effect. An implantable nerve stimulator features the combination of a nuclear battery and electronic circuitry providing signals consisting of a train of a controlled number of pulses of direct current. An implantable respiratory pacer having an output of a range of from about 1 to 5 milliwatts and powered by a nuclear battery stimulates one or more phrenic nerve to provide a controlled rate of breathing for the mammal.
DRAWING A schematic plan for the apparatus is shown in the drawing. In the drawing, which is essentially selfexplanatory, a respiratory pacer 10 features a nuclear battery 11. Within the nuclear battery, a radioisotope heat source 12 energizes a thermopile 13 to generate a voltage energizing the respiratory pacer. The battery voltage is modified by a voltage amplifier l4 and a constant voltage regulator 15. Electrical circuit means energized by the voltage from said regulator 15 energizes a pulse generator, the electrical circuitry for such pulse generator comprising an oscillator. A pulse train generator 17 assures the absence of current flow during significant intervals, with a train of pulses between intervals, for example, 18 intervals per minute, corresponding to a relaxed breathing rate. A signal amperage modulator 18 transforms each train of pulses into a saw tooth signal having an end peak from per cent to per cent to the initial portion of such signal, thus more nearly simulating the natural signal to a phrenic nerve. Conductors l9 and 20 transmit such saw tooth signal to left and/or right phrenic nerves. The electrical circuit means and nuclear battery are hermetically sealed in a casing 21.
As seen in the flow pattern, the combination of radioisotope thermopile, and voltage amplifier to provide a source of useful voltage is consistent with prior teach-,
ings concerning nucleonic powered cardiac pacers. The combination of a constant voltage regulator and a pulse generator is also previously taught in connection with nerve stimulators.
The provision of a pulse train generator to provide a signal consisting of a controlled series of direct current pulses is a novel feature of the present nerve stimulator.
The step of modulating the amperage to provide a saw tooth signal having an end peak from 125 per cent to 195 per centof the initial portion of a signal is a novel and significant forward step of the present invention.
Previous nervestimulators have generally lacked the novel adjustable 'means for allocating electrical energy amongst a plurality of conductors, so that the provision of the load isolation and distribution regulator should be given special consideration.
This invention represents a medical break-through as the first device adapted for placement or implantation within the body and featuring the combination of nucleonic battery and a conduit stimulating the phrenic nerve. The unique'nuclear battery makes feasible the first respiratory pacer sufficiently durable and compact to be carried within the body after surgical implantation.
DETAILED DESCRIPTION OF THE INVENTION In a preferredv embodiment, the nerve stimulator serves to actuate the phrenic nerve to provide a respiratory pacer. A radioisotope provides a continuing radioactivity which is transformed into heat and the heat is transformed into a low voltage electric current. A voltage amplifier converts the DC voltage to a more useful direct current voltage which is maintained constant by a constant voltage regulator. A self-starting oscillator regulates the conversion of the constant direct current to a square wave series of direct current pulses having a frequency of about 90 pulses per second, each pulse having a duration of about 132 microseconds.
A significant difference from a conventional cardiac pacer concerns a pulse train generator adapted to provide a train of pulses followed by an interval each signal being a train of pulses. For a respiratory pacer, about 18 signals per minute are appropriate, the interval between the signals being about 24 per cent greater than the signal duration. Each signal can be about 1.49 seconds and the interval between signals about 1.85 seconds.
Important advantages are attained by reason of the provision of a signal consisting of a plurality of direct current pulses. Certain biochemical phenomena are apparently associated with a neurological electrical system. Although certain neurological effects can be achieved by a signal partaking of the nature of a single electrical pulse, better simulation of the neurological signal is achieved by providing the train of pulsation of direct current.
An important feature of the present invention is the provision of a modulator adapted to alter the train of pulses in a signal so that the peak amperage during a particular signal is at least 25 per cent greater than the minimum amperage during such signal. Various patterns of modulation of the signal are appropirate but particular advantages arise from the control of a saw tooth train having a relatively lower amperage at the beginning of the signal than at the end of the signal, with the amperage increasing during the continuation of the signal. It is sometimes desirable for a signal remote from this invention to have a saw tooth pattern involving an increase which is several hundred per cent over the minimum amperage but such a steep increase in amperage during the signal does not appear to closely simulate a neurological signal. The saw tooth increase modulates the signal so that the amperage of the terminal portion of the signal of the present invention is from about 125 per cent to about 195 per cent of the amperage of the initial signal, whereby the simulation of the natural neurological signal is more accurately achieved.
The disfunction impairing the operation of the phrenic nerves is often not the same for the right phrenic nerve and left phrenic nerve. Accordingly, a load isolation regulator is advantageously included in the respiratory pacer to permit adjustment of the intensity of the phrenic nerve signal for each of the two nerves; that is, the left phrenic nerve and the right phrenic nerve. A manually adjustable potentiometer can split the power between the two phrenic nerves. A conductor extends from the respiratory pacer to the phrenic nerve. Such conductor is advantageously detachably connected to the respiratory pacer.
A preferred embodiment of the invention can be further clarified by description of a respiratory pacer.
Nuclear Battery Plutonium 238 has a half life of 86.4 years, and has numerous advantages for a nuclear battery. About 2 watts of power are generated, theoretically, by the amount of plutonium employed in the battery, but much of the energy is dissipated. The electrical output of the battery is of the general magnitude of the range of 0.001 to 0.005 watt, or about I to milliwatts. The energy utilization efficiency of the battery and/or nerve stimulator is in the range from about 0.1 per cent to l per cent. A plutonium-type battery having a size of about 1 /2 inches diameter and l l/16 inch thick weighs about 92 grams.
The voltage resulting from a thermocouple is amplified by a DC voltage amplifier to provide the electric current suitable for the electronic circuitry. The oscillator modifies the current by a square wave series of pulses of direct current having a frequency of about 89 pulses per second. Each pulse has a width or duration of about 132 microseconds or 0.132 milliseconds.
A pulse train generator transforms the pulses into signals at a range of about 18 signals per minute, the intervals between signals being about 24 per cent greater than the duration of the signals. The signal is about l.49 seconds and the interval between signals about 1.85 seconds. The maximum pulse amplitude is about 9.6 milliamps. The pulse amplitude modulation is about 54 per cent. The maximum amperage is within the range from per cent to per cent of the minimum amperage by reason of the control of the modulation of the signal.
Casing The respiratory pacer is hermetically sealed in a flat cylindrically shaped titanium can having a diameter of about 2% inches and about 1% inches thick. Such hermetic sealing protects the contents from adverse effects of liquids between organs within the body, whereby it may be implanted within a living body. The respiratory pacer weighs about 198 grams, thus being similar in weight and dimensions to a battery powered cardiac pacer having an output of about one-twentieth of the power of a phrenic nerve stimulator.
A signal having a saw tooth shape can have a substantially uniform increase of amperage during the 1.49 seconds of the signal. The modulation circuitry is adapted to provide up to about 54 per cent modulation of the maximum signal and to achieve saw tooth wave signal. In the development of the present invention, it has been established that the maximum amperage of the signal should be at least 25 per cent greater than the minimum amperage of the signal, and should be less than 95 per cent of such minimum.
It should be noted that a train of pulses which has not been modulated tends to stimulate staccato breathing. Such unnatural staccato breathing is harmful to the health. The modulation of the signal to the phrenic nerve so that the amperage during the terminal portion of the signal is significantly greater (for example, about 50 per cent) than the initial amperage promotes a breathing pattern which closely simulates that which the autonomic nervous system would stimulate in a healthy individual.
Various modifications of the invention are appropriate without departing from the scope of the appended claims.
The invention claimed is:
1. In a respiratory pacer, the combination of:
a nuclear battery providing several years of useful life;
electrical means converting electrical power from said battery to a series of signals having a frequency per minute corresponding approximately to the desired breathing rate, each signal comprising a plurality of direct current pulses, one output terminal being a connector and the other output terminal for said electrical means being the hereinafter recited casing adapted to contact liquids between organs within the body, some such liquids being where the pacer is implanted, said electrical means including means for modulating the amperage of a signal so that its maximum amperage is within the range from about 125 per cent to about 195 per cent of the minimum amperage of such signal;
at least one conductor transmitting signals from said connector toward a phrenic nerve; and
a casing containing said battery, electrical means, and said connector for said conductor, said casing hermetically sealing its contents from adverse effects attributable to said liquids, whereby the respiratory pacer may be implanted within a living body.
2. In an implantable nerve stimulator comprising at least one conductor transmitting signals toward a nerve, the improvement which includes:
a casing;
hermetic sealing means for said casing adapted to protect the contents of the casing from adverse effects attributable to liquids between organs;
a nucleonic battery within the casing; 7
means conducting current from said battery to the hereinafter recited circuit means; and
electrical circuit means converting electrical power from said battery to signals consisting of a controlled train of direct current pulses transmitted by said conductor, said circuit means including means for modulating the amperage of a signal so that its maximum amperage is within the range from about per cent to about per cent of the minimum amperage of such signal.
3. The nerve stimulator of claim 2 in which the train of pulses constituting said signal has'a sawtooth pattern with maximum amperage at about the terminal portion of the signal and a minimum amperage at about the initial portion of the signal.
4. The nerve stimulator of claim 2 in which there are a plurality of conductors and manually adjustable distribution means allocating the signal energy flowing respectively toward the right phrenic nerve and the left phrenic nerve.
5. A nuclear powered respiratory pacer in accordance with claim 2 in which the output flowing toward at least one phrenic nerve is within the range from about 1 to about 5 milliwatts.
6. A nuclear powered respiratory pacer in accordance with claim 5 in which the nuclear battery weighs about 92 grams and contains plutonium 23 8 as the radioisotope heat source.

Claims (6)

1. In a respiratory pacer, the combination of: a nuclear battery providing several years of useful life; electrical means converting electrical power from said battery to a series of signals having a frequency per minute corresponding approximately to the desired breathing rate, each signal comprising a plurality of direct current pulses, one output terminal being a connector and the other output terminal for said electrical means being the hereinafter recited casing adapted to contact liquids between organs within the body, some such liquids being where the pacer is implanted, said electrical means including means for modulating the amperage of a signal so that its maximum amperage is within the range from about 125 per cent to about 195 per cent of the minimum amperage of such signal; at least one conductor transmitting signals from said connector toward a phrenic nerve; and a casing containing said battery, electrical means, and said connector for said conductor, said casing hermetically sealing its contents from adverse effects attributable to said liquids, whereby the respiratory pacer may be implanted within a living body.
2. In an implantable nerve stimulator comprising at least one conductor transmitting signals toward a nerve, the improvement which includes: a casing; hermetic sealing means for said casing adapted to protect the contents of the casing from adverse effects attributable to liquids between organs; a nucleonic battery within the casing; means conducting current from said battery to the hereinafter recited circuit means; and electrical circuit means converting electrical power from said battery to signals consisting of a controlled train of direct current pulses transmitted by said conductor, said ciRcuit means including means for modulating the amperage of a signal so that its maximum amperage is within the range from about 125 per cent to about 195 per cent of the minimum amperage of such signal.
3. The nerve stimulator of claim 2 in which the train of pulses constituting said signal has a sawtooth pattern with maximum amperage at about the terminal portion of the signal and a minimum amperage at about the initial portion of the signal.
4. The nerve stimulator of claim 2 in which there are a plurality of conductors and manually adjustable distribution means allocating the signal energy flowing respectively toward the right phrenic nerve and the left phrenic nerve.
5. A nuclear powered respiratory pacer in accordance with claim 2 in which the output flowing toward at least one phrenic nerve is within the range from about 1 to about 5 milliwatts.
6. A nuclear powered respiratory pacer in accordance with claim 5 in which the nuclear battery weighs about 92 grams and contains plutonium 238 as the radioisotope heat source.
US277963A 1971-08-06 1972-08-04 Implantable nerve stimulator Expired - Lifetime US3896817A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP8644973A JPS4992885A (en) 1972-08-04 1973-08-02
FR7328542A FR2194456B1 (en) 1972-08-04 1973-08-03
BE1005277A BE803162A (en) 1972-08-04 1973-08-03 IMPLANTABLE NERVE STIMULATOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3715171A GB1410761A (en) 1971-08-06 1971-08-06 Implantable respiratory pacer

Publications (1)

Publication Number Publication Date
US3896817A true US3896817A (en) 1975-07-29

Family

ID=10394170

Family Applications (1)

Application Number Title Priority Date Filing Date
US277963A Expired - Lifetime US3896817A (en) 1971-08-06 1972-08-04 Implantable nerve stimulator

Country Status (2)

Country Link
US (1) US3896817A (en)
GB (1) GB1410761A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4662884A (en) * 1984-04-25 1987-05-05 University Of Utah Research Foundation Prostheses and methods for promoting nerve regeneration
US4778467A (en) * 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US4934368A (en) * 1988-01-21 1990-06-19 Myo/Kinetics Systems, Inc. Multi-electrode neurological stimulation apparatus
US5038781A (en) * 1988-01-21 1991-08-13 Hassan Hamedi Multi-electrode neurological stimulation apparatus
US5678535A (en) * 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
WO1998042405A1 (en) 1997-03-27 1998-10-01 Hashem Sultan Voice activated locomotor device and method of use
WO2001041868A1 (en) * 1999-12-09 2001-06-14 Cardiac Pacemakers, Inc. Method and apparatus for diaphragmatic pacing
US20030105499A1 (en) * 1998-02-27 2003-06-05 Cardiac Pacemakers, Inc. Rate adaptive cardiac rhythm management device using transthoracic impedance
US6961623B2 (en) * 2002-10-17 2005-11-01 Rehabtronics Inc. Method and apparatus for controlling a device or process with vibrations generated by tooth clicks
US20060111755A1 (en) * 2003-05-16 2006-05-25 Stone Robert T Method and system to control respiration by means of neuro-electrical coded signals
US20060122661A1 (en) * 2004-12-03 2006-06-08 Mandell Lee J Diaphragmatic pacing with activity monitor adjustment
US8050764B2 (en) 2003-10-29 2011-11-01 Cardiac Pacemakers, Inc. Cross-checking of transthoracic impedance and acceleration signals
US8209011B2 (en) 2002-12-30 2012-06-26 Cardiac Pacemakers, Inc. Automatically configurable minute ventilation sensor
US8306621B2 (en) 2003-07-02 2012-11-06 Cardiac Pacemakers, Inc. Cardiac cycle synchronized sampling of impedance signal

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566276B1 (en) * 1984-06-21 1988-07-08 Medtronic Bv DIAPHRAGMATIC STIMULATION METHOD AND APPARATUS
US5036848A (en) * 1989-10-16 1991-08-06 Brunswick Biomedical Technologies, Inc. Method and apparatus for controlling breathing employing internal and external electrodes
US10699820B2 (en) 2013-03-15 2020-06-30 Lawrence Livermore National Security, Llc Three dimensional radioisotope battery and methods of making the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2711729A (en) * 1951-06-13 1955-06-28 Fastel Corp Inc Apparatus for the stimulation of respiration and electrorespirator
US3077884A (en) * 1957-06-13 1963-02-19 Batrow Lab Inc Electro-physiotherapy apparatus
US3486506A (en) * 1965-10-13 1969-12-30 Philips Corp Heart-actuated,spring driven cardiac stimulator
US3600586A (en) * 1967-11-09 1971-08-17 Commissuriat A L En Atomique {60 -ray heat source, suitable for use in a cardiac pacemaker
US3649367A (en) * 1966-06-02 1972-03-14 Nuclear Materials & Equipment Electrical generator

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2711729A (en) * 1951-06-13 1955-06-28 Fastel Corp Inc Apparatus for the stimulation of respiration and electrorespirator
US3077884A (en) * 1957-06-13 1963-02-19 Batrow Lab Inc Electro-physiotherapy apparatus
US3486506A (en) * 1965-10-13 1969-12-30 Philips Corp Heart-actuated,spring driven cardiac stimulator
US3649367A (en) * 1966-06-02 1972-03-14 Nuclear Materials & Equipment Electrical generator
US3600586A (en) * 1967-11-09 1971-08-17 Commissuriat A L En Atomique {60 -ray heat source, suitable for use in a cardiac pacemaker

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4662884A (en) * 1984-04-25 1987-05-05 University Of Utah Research Foundation Prostheses and methods for promoting nerve regeneration
US4778467A (en) * 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US4934368A (en) * 1988-01-21 1990-06-19 Myo/Kinetics Systems, Inc. Multi-electrode neurological stimulation apparatus
US5038781A (en) * 1988-01-21 1991-08-13 Hassan Hamedi Multi-electrode neurological stimulation apparatus
US5678535A (en) * 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
US5911218A (en) * 1995-04-21 1999-06-15 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
WO1998042405A1 (en) 1997-03-27 1998-10-01 Hashem Sultan Voice activated locomotor device and method of use
US20030105499A1 (en) * 1998-02-27 2003-06-05 Cardiac Pacemakers, Inc. Rate adaptive cardiac rhythm management device using transthoracic impedance
WO2001041868A1 (en) * 1999-12-09 2001-06-14 Cardiac Pacemakers, Inc. Method and apparatus for diaphragmatic pacing
US6415183B1 (en) 1999-12-09 2002-07-02 Cardiac Pacemakers, Inc. Method and apparatus for diaphragmatic pacing
US6961623B2 (en) * 2002-10-17 2005-11-01 Rehabtronics Inc. Method and apparatus for controlling a device or process with vibrations generated by tooth clicks
US8209011B2 (en) 2002-12-30 2012-06-26 Cardiac Pacemakers, Inc. Automatically configurable minute ventilation sensor
US8423142B2 (en) 2002-12-30 2013-04-16 Cardiac Pacemakers, Inc. Cross-checking of transthoracic impedance and acceleration signals
US20060111755A1 (en) * 2003-05-16 2006-05-25 Stone Robert T Method and system to control respiration by means of neuro-electrical coded signals
US8306621B2 (en) 2003-07-02 2012-11-06 Cardiac Pacemakers, Inc. Cardiac cycle synchronized sampling of impedance signal
US8442633B2 (en) 2003-07-02 2013-05-14 Cardiac Pacemakers, Inc. Cardiac cycle synchronized sampling of impedance signal
US8688214B2 (en) 2003-07-02 2014-04-01 Cardiac Pacemakers. Inc. Cardiac cycle synchronized sampling of impedance signal
US8880171B2 (en) 2003-07-02 2014-11-04 Cardiac Pacemakers, Inc. Cardiac cycle synchronized sampling of impedance signal
US8050764B2 (en) 2003-10-29 2011-11-01 Cardiac Pacemakers, Inc. Cross-checking of transthoracic impedance and acceleration signals
US20060122661A1 (en) * 2004-12-03 2006-06-08 Mandell Lee J Diaphragmatic pacing with activity monitor adjustment

Also Published As

Publication number Publication date
GB1410761A (en) 1975-10-22

Similar Documents

Publication Publication Date Title
US3896817A (en) Implantable nerve stimulator
US4889526A (en) Non-invasive method and apparatus for modulating brain signals through an external magnetic or electric field to reduce pain
US5217009A (en) Compact biomedical pulsed signal generator for bone tissue stimulation
US4993413A (en) Method and apparatus for inducing a current and voltage in living tissue
CN100478042C (en) Apparatus and method for bioelectric stimulation, healing acceleration and pain relief
EP0223354A2 (en) Apparatus for modulating brain signals through an external magnetic field to reduce pain
US4308868A (en) Implantable electrical device
US6731979B2 (en) Pulse width cardiac pacing apparatus
GB1422845A (en) Transcutaneous stimulator
US4018218A (en) Method and apparatus for sleep induction
US5413596A (en) Digital electronic bone growth stimulator
GB9211085D0 (en) Electrical stimulation
DE2965791D1 (en) Apparatus for tachycardia investigation or control
HK34090A (en) Apparatus for treatment of living tissue by stimulation by means of pulses of electric current and/or by means of electro-magnetic waves
ATE145343T1 (en) ELECTROTHERAPY DEVICE
JP2006509557A (en) Externally actuated neural implants that send therapeutic signals directly
IE912227A1 (en) Method and device for the treatment of epilepsy
KR20120091256A (en) Implant device for stimulating osteogenesis and osseointegration
RU2178319C2 (en) Electric stimulator
ATE116140T1 (en) ELECTRICAL STIMULATION DEVICE.
FR2417977A1 (en) DEVICE FOR MODIFYING PULSES PRODUCED BY A GENERATOR WHICH IS PART OF A HEART STIMULATOR
NL7806850A (en) Heart pacemaker and QRS wave function monitor - stimulates ventricle and atrium in time related sequence when required
Clark et al. A multi-channel hearing prosthesis for profound-to-total hearing loss
Sanders et al. Transcutaneous electrical stimulation of the recurrent laryngeal nerve in monkeys
Smith Miniature stimulator for chronic animals

Legal Events

Date Code Title Description
AS Assignment

Owner name: BRAZOSPORT BANK OF TEXAS

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIA

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: CITIBANK, N.A., AS AGENT

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: FIRST NATIONAL BANK OF CHICAGO, THE

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: CHASE MANHATTAN BANK, N.A., THE

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: FIRST FREEPORT NATIONAL BANK

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: TRUST COMPANY BANK

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

AS Assignment

Owner name: CHASE COMMERCIAL CORPORATION

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A CORP. OF TEXAS;INTERMEDICS CARDIASSIST, INC., A CORP OF TX.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004449/0501

Effective date: 19850703

Owner name: CITICORP MILTILEASE (SEF), INC.

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004452/0900

Effective date: 19850703

Owner name: CITIBANK, N.A.

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A TX CORP;INTERMEDICS CARDIASSIST, INC., A TX CORP.;INTERMEDICS INTRAOCULAR, INC., A TX CORP.;AND OTHERS;REEL/FRAME:004434/0728

Effective date: 19850703

Owner name: B.A. LEASING CORPORATION

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A CORP. OF TEXAS;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004449/0424

Effective date: 19850703

AS Assignment

Owner name: INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC.,

Free format text: SECURED PARTY HEREBY RELEASE THE SECURITY INTEREST IN AGREEMENT RECORDED AUGUST 5, 1985. REEL 4434 FRAMES 728-782;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:004592/0394

Effective date: 19860502

Owner name: INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC.,

Free format text: SAID PARTIES RECITES OBLIGATIONS RECITED IN SECURITY AGREEMENT RECORDED SEPTEMBER 17, 1984 REEL 4303 FRAMES 077-127 HAVE BEEN PAID IN FULL ALL;ASSIGNOR:CITIBANK, N.A., INDIVIDUALLY AND AS AGENT FOR BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION, THE CHASE MANHATTAN BANK, N.A., THE FIRST NATIONAL BANK OF CHICAGO, TRUST COMPANY BANK, FIRST FREEPORT NATIONAL BANK OF BRAZOSPORT BANK OF TEXAS;REEL/FRAME:004592/0424

Effective date: 19860502

Owner name: INTERMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CITICORP MULTILEASE (SEF), INC.;REEL/FRAME:004576/0516

Effective date: 19860515

AS Assignment

Owner name: MAY PARTNERSHIP THE, 2170 PIEDMONT ROAD, N.E., ATL

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.,;INTERMEDICS CARDIASSIST, INC.;SURGITRONICS CORPORATION;AND OTHERS;REEL/FRAME:004581/0501

Effective date: 19860703

Owner name: MAY PARTNERSHIP, THE,GEORGIA

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.,;INTERMEDICS CARDIASSIST, INC.;SURGITRONICS CORPORATION;AND OTHERS;REEL/FRAME:004581/0501

Effective date: 19860703

AS Assignment

Owner name: INTERMEDICS, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS CARDIASSIST, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: SURGITRONICS CORPORATION, A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CARBOMEDICS, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: NEUROMEDICS, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CALCITEK, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: AMERICAN PACEMAKER CORPORATION, A MASSACHUSETTS CO

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: INTERMEDICS CARDIASSIST, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: INTERMEDICS INTRAOCULAR, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: SURGITRONICS CORPORATION

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: CARBO-MEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: NEUROMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: CALCITEK, INC., ALL TEXAS CORPS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: AMERICAN PACEMAKER CORPORATION A CORP OF MA

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: INTERMEDICS, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS CARDIASSIST, INC., A TEXAS CORP., STAT

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP., STAT

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: SURGITRONICS CORPORATION, A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CARBOMEDICS, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: NEUROMEDICS, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CALCITEK, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

AS Assignment

Owner name: INTERMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:MAY PARTNERSHIP, THE, BY: ROLLINS HOLDING COMPANY, INC.;REEL/FRAME:004874/0945

Effective date: 19870112